Today’s Top Three in Pharma 012309

BREAKING RUMOR – Pfizer in talks to acquire Wyeth.

Will contract sales reps rule in the future? Revenues are now following a “cyclical pattern surrounding patent expirations,” In Vivo quotes Ryan as saying. So pharma companies need to have sales forces that can follow the same kind of cycle, shrinking as revenues sink, she suggests.

Merck’s Januvia + metformin for diabetes, 2 years in – looking good. Merck & Co’s diabetes drug Januvia substantially improves blood sugar levels over two years of treatment when combined with the older drug metformin and is generally well tolerated, new data on Tuesday showed.

Hmmm…will names of BI reps who signed onto a class action suit become known to their bosses?

—––

Subscribe to the Impactiviti blog via e-mail

Subscribe to the Impactiviti blog via RSS

Impactiviti is a pharma consultancy focused on helping pharma/biotech/medical devices companies identify optimal vendors for training/marketing needs.